Adults with relapsed B-cell acute lymphoblastic leukaemia (ALL) might achieve durable responses to chimeric antigen receptor (CAR) T-cell therapy, according to recent findings.
Original Article: [News] CAR T-cells for relapsed B-cell ALL in adults
NEXT ARTICLE